TY - JOUR
T1 - The temporal pattern of immune and inflammatory proteins prior to a recurrent coronary event in post-acute coronary syndrome patients
AU - Vroegindewey, Maxime M
AU - Oemrawsingh, Rohit M
AU - Kardys, Isabella
AU - Asselbergs, Folkert W
AU - van der Harst, Pim
AU - Oude Ophuis, Anton J
AU - Etienne Cramer, G
AU - Maas, Arthur
AU - Hong Kie The, S
AU - Wardeh, Alexander J
AU - Mouthaan, Henk
AU - Boersma, Eric
AU - Akkerhuis, K Martijn
PY - 2019/3
Y1 - 2019/3
N2 - Purpose: We assessed the temporal pattern of 29 immune and inflammatory proteins in post-acute coronary syndrome (ACS) patients, prior to the development of recurrent ACS. Methods: High-frequency blood sampling was performed in 844 patients admitted for ACS during one-year follow-up. We conducted a case-control study on the 45 patients who experienced reACS (cases) and two matched event-free patients (controls) per case. Olink Proteomics’ immunoassay was used to obtain serum levels of the 29 proteins, expressed in an arbitrary unit on the log2-scale (Normalized Protein eXpression, NPX). Linear mixed-effects models were applied to examine the temporal pattern of the proteins, and to illustrate differences between cases and controls. Results: Mean age was 66 ± 12 years and 80% were men. Cases and controls had similar baseline clinical characteristics. During the first 30 days, and after multiple testing correction, cases had significantly higher serum levels of CXCL1 (difference of 1.00 NPX, p = 0.002), CD84 (difference of 0.64 NPX, p = 0.002) and TNFRSF10A (difference of 0.41 NPX, p < 0.001) than controls. After 30 days, serum levels of all 29 proteins were similar in cases and controls. In particular, no increase was observed prior to reACS. Conclusions: Among 29 immune and inflammatory proteins, CXCL1, CD84 and TNFRSF10A were associated with early reACS after initial ACS-admission.
AB - Purpose: We assessed the temporal pattern of 29 immune and inflammatory proteins in post-acute coronary syndrome (ACS) patients, prior to the development of recurrent ACS. Methods: High-frequency blood sampling was performed in 844 patients admitted for ACS during one-year follow-up. We conducted a case-control study on the 45 patients who experienced reACS (cases) and two matched event-free patients (controls) per case. Olink Proteomics’ immunoassay was used to obtain serum levels of the 29 proteins, expressed in an arbitrary unit on the log2-scale (Normalized Protein eXpression, NPX). Linear mixed-effects models were applied to examine the temporal pattern of the proteins, and to illustrate differences between cases and controls. Results: Mean age was 66 ± 12 years and 80% were men. Cases and controls had similar baseline clinical characteristics. During the first 30 days, and after multiple testing correction, cases had significantly higher serum levels of CXCL1 (difference of 1.00 NPX, p = 0.002), CD84 (difference of 0.64 NPX, p = 0.002) and TNFRSF10A (difference of 0.41 NPX, p < 0.001) than controls. After 30 days, serum levels of all 29 proteins were similar in cases and controls. In particular, no increase was observed prior to reACS. Conclusions: Among 29 immune and inflammatory proteins, CXCL1, CD84 and TNFRSF10A were associated with early reACS after initial ACS-admission.
KW - Acute coronary syndrome
KW - biomarkers
KW - immune and inflammatory system
KW - proteins
KW - proteomics
KW - temporal pattern
KW - Humans
KW - Middle Aged
KW - Male
KW - Immunity, Innate/genetics
KW - Inflammation/blood
KW - Receptors, TNF-Related Apoptosis-Inducing Ligand/genetics
KW - Acute Coronary Syndrome/blood
KW - Proteomics
KW - Biomarkers/blood
KW - Female
KW - Aged
KW - Chemokine CXCL1/genetics
KW - Signaling Lymphocytic Activation Molecule Family/genetics
UR - http://www.scopus.com/inward/record.url?scp=85058129180&partnerID=8YFLogxK
U2 - 10.1080/1354750X.2018.1539768
DO - 10.1080/1354750X.2018.1539768
M3 - Article
C2 - 30514120
SN - 1354-750X
VL - 24
SP - 199
EP - 205
JO - Biomarkers
JF - Biomarkers
IS - 2
ER -